The NPM1 gene bears frequent mutations in hematological diseases, especially in AML, with approximately 30% of patients harbouring a frameshift mutation resulting in aberrant NPM1 cytoplasmic localisation (NPMc+) [62]. Here, NPM1 is linked to acute myeloid leukemia.